Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Michael Narkewicz to Epstein-Barr Virus Infections

This is a "connection" page, showing publications Michael Narkewicz has written about Epstein-Barr Virus Infections.

 
Connection Strength
 
 
 
0.765
 
  1. Narkewicz MR, Green M, Dunn S, Millis M, McDiarmid S, Mazariegos G, Anand R, Yin W. Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience. Liver Transpl. 2013 Jul; 19(7):730-40.
    View in: PubMed
    Score: 0.388
  2. Lu BR, Fenton LZ, O'Connor J, Narkewicz MR. Epstein-Barr virus-related optic neuritis as a precursor to the development of posttransplant lymphoproliferative disease. J Pediatr Gastroenterol Nutr. 2009 Aug; 49(2):243-5.
    View in: PubMed
    Score: 0.296
  3. Holmes RD, Orban-Eller K, Karrer FR, Rowe DT, Narkewicz MR, Sokol RJ. Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome. Transplantation. 2002 Aug 15; 74(3):367-72.
    View in: PubMed
    Score: 0.046
  4. Feranchak AP, Tyson RW, Narkewicz MR, Karrer FM, Sokol RJ. Fulminant Epstein-Barr viral hepatitis: orthotopic liver transplantation and review of the literature. Liver Transpl Surg. 1998 Nov; 4(6):469-76.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)